| Sanofi-Aventis (Suisse) SA - Zaltrap 100 mg/4 ml, concentré pour solution pour perfusion | | 62676 | | 01 | | Zaltrap 100 mg/4 ml | | concentré pour solution pour perfusion | | L01XX44 | | Aflibercept | | 20.03.2013 | | |
| | Composition | | afliberceptum 100 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum citricum monohydricum, natrii citras dihydricus, natrii chloridum, saccharum, polysorbatum 20, aqua ad iniectabile, q.s. ad solutionem pro 4 ml. | | Packungsbestandteile | | concentré pour solution pour perfusion | | | | | | | | Active Agent | Dose |
|---|
| Afliberceptum | 100mg / 4ml |
| | BAG: Active Agent | Dose |
|---|
| Afliberceptum | 100 mg |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Disodium Phosphate Heptahydrate | | Sodium Chloride | | Natrii Citras Dihydricus | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 20 | | Saccharum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 388.94 | 439.40 | A | SL | Yes |
|
|
